Re: Thoughts on ZCC
in response to
by
posted on
Sep 13, 2021 05:34PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I hope folks who push for DM to leave have your post bookmarked. Dreams of a new CEO to turn your shares into vast riches can easily turn into a nightmare.